Advanced Biomed Inc Deferred Costs, Noncurrent
Advanced Biomed Inc (ADVB) had Deferred Costs, Noncurrent of $672.47 thousand as of 2024-12-31, per its 10-Q filed 2025-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2025-10-08
- 2024-12-31: Deferred Costs, Noncurrent $672.47K.
- 2024-06-30: Deferred Costs, Noncurrent $638.87K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2024-12-31 | $672.47K 10-Q · filed 2025-04-15 |
| 2024-06-30 | $638.87K 10-K · filed 2025-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |